>
Iran signals re-closure of Hormuz as it rejects uranium transfer abroad
Goodbye leather bondage gear, hello traditional nuclear family…
10 Essential Barter Items When the Grid Goes Dark
The Number of Dead Iranian Protesters Keeps Changing Because It's a Fictional Story
Researchers Turn Car Battery Acid and Plastic Waste into Clean Hydrogen and New Plastic
'Spin-flip' system pushes solar cell energy conversion efficiency past 100%
A Startup Has Been Quietly Pitching Cloned Human Bodies to Transfer Your Brain Into
DEYE 215kWh LiFePO4 + 125,000W Inverter + 200,000W MPPT = Run A Factory Offgrid!!
China's Unitree Unveils Robot With "Human-Like Physique" That Can Outrun Most People
This $200 Black Shaft Air Conditions Your Home For Free Forever -- Why Is It Banned in the U.S.?
Engineers have developed a material capable of self-repairing more than 1,000 times,...
They bypassed the eye entirely.
The Most Dangerous Race on Earth Isn't Nuclear - It's Quantum.

A groundbreaking study published in the Journal of Biomolecular Structure and Dynamics suggests just that — revealing how a natural compound found in licorice root might be a powerful weapon against breast cancer.
The sweet science behind glycyrrhizin
Glycyrrhizin, the active ingredient in licorice root responsible for its sweetness, has been used for centuries in traditional medicine to treat everything from sore throats to digestive issues. But now, researchers are uncovering its potential as a natural cancer-fighting agent. (Related: Licorice contains powerful cancer-killing phytochemicals.)
Using advanced computer modeling and bioinformatics — a subdiscipline of biology and computer science that uses software tools to analyze and interpret biological data — Iranian researchers mapped out exactly how this compound interacts with breast cancer cells, and the results are promising.
The study dug deep into the molecular pathways glycyrrhizin takes to combat cancer. Specifically, it focused on the breast cancer genes glycyrrhizin targets and how the compound interacts with the genes' protein products.
Of the 10 breast cancer-related genes the researchers looked at, they found that glycyrrhizin showed the highest binding affinity to three genes, namely, POLK, TBXAS1 and ADRA1A. These genes are active in three types of breast cancer: breast carcinoma, malignant neoplasm of the breast and triple-negative breast neoplasms.
The researchers reported that the protein products of these genes "had an association with [breast cancer] at several stages of tumor growth." By binding to and influencing the activities of these targets, glycyrrhizin is able to influence and control breast cancer growth and survival efficiently.
Molecular dynamics simulation also revealed that of the three interactions mapped out by the study, the destructive pathways triggered by glycyrrhizin's binding to ADRA1A had the highest likelihood of occurring.